Arthur Kuan - 24 Jan 2024 Form 3 Insider Report for CG Oncology, Inc. (CGON)

Role
Chief Executive Officer, Director
Signature
/s/ Corleen Roche, Attorney-in-Fact for Arthur Kuan
Issuer symbol
CGON
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
3
Filing time
24 Jan 2024, 21:05:37 UTC
Next filing
07 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGON Common Stock 36,151 24 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGON Stock Option 24 Jan 2024 Common Stock 167,483 $1.72 Direct F1
holding CGON Stock Option 24 Jan 2024 Common Stock 298,243 $2.29 Direct F2
holding CGON Stock Option 24 Jan 2024 Common Stock 524,383 $6.68 Direct F3
holding CGON Stock Option 24 Jan 2024 Common Stock 83,901 $12.59 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is currently vested and exercisable.
F2 The stock option vests in 35 substantially equal monthly installments beginning on December 19, 2023.
F3 The stock option vests in 48 substantially equal monthly installments beginning on October 20, 2023.
F4 The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.

Remarks:

Exhibit 24 - Power of Attorney.